MARKET

SXTPW

SXTPW

60 Degrees Pharm
NASDAQ
0.0798
0.0000
0.00%
Closed 09:30 03/27 EDT
OPEN
0.0798
PREV CLOSE
0.0798
HIGH
0.0798
LOW
0.0798
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.1560
52 WEEK LOW
0.0200
MARKET CAP
--
P/E (TTM)
-0.0035
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SXTPW last week (0316-0320)?
Weekly Report · 6d ago
60 Degrees Pharmaceuticals corrects affiliate beneficial ownership to 23,367 shares
Reuters · 03/20 20:15
60 Degrees Pharmaceuticals files NDIN with FDA for Australian Chestnut Extract
Reuters · 03/18 12:38
60 DEGREES PHARMACEUTICALS INC - FDA HAS UNTIL MAY 25, 2026 TO OBJECT TO NDIN FOR AUSTRALIAN CHESTNUT EXTRACT
Reuters · 03/18 12:01
Weekly Report: what happened at SXTPW last week (0309-0313)?
Weekly Report · 03/16 09:38
60 Degrees Pharmaceuticals files updated legal opinion for ATM equity offering program
Reuters · 03/12 20:41
60 Degrees Pharmaceuticals reports 100% babesiosis cure rate in tafenoquine expanded access trial
Reuters · 03/11 11:24
60 DEGREES PHARMACEUTICALS ANNOUNCES ALL PATIENTS CURED OF BABESIOSIS AFTER TAFENOQUINE TREATMENT IN EXPANDED USE CLINICAL TRIAL
Reuters · 03/11 11:24
More
About SXTPW
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

Webull offers 60 Degrees Pharmaceuticals Inc stock information, including NASDAQ: SXTPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SXTPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SXTPW stock methods without spending real money on the virtual paper trading platform.